Sandbox: sadaf: Difference between revisions
Jump to navigation
Jump to search
Line 5: | Line 5: | ||
{| | {| | ||
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Category | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Category | ||
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + | | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Subcategory | ||
! colspan="2" rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + | | ! colspan="2" rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Disease | ||
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |History | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |History | ||
! colspan="6" align="center" style="background:#4479BA; color: #FFFFFF;" + |Clinical manifestation | ! colspan="6" align="center" style="background:#4479BA; color: #FFFFFF;" + |Clinical manifestation | ||
Line 24: | Line 24: | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |TT | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |TT | ||
|- | |- | ||
! rowspan=" | ! rowspan="16" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Platelet disorders | ||
! rowspan="7" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Thrombocytopenia]] | ! rowspan="7" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Thrombocytopenia]] | ||
! colspan="2" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Infection]]-Induced [[thrombocytopenia]]<span name="harr_c115s002s001s002p001"></span><span name="9100754"></span> | ! colspan="2" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Infection]]-Induced [[thrombocytopenia]]<span name="harr_c115s002s001s002p001"></span><span name="9100754"></span> | ||
Line 158: | Line 158: | ||
| align="center" style="background:#F5F5F5;" | Nl | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="center" style="background:#F5F5F5;" | − | | align="center" style="background:#F5F5F5;" | − | ||
|- | |||
!Subcategory | |||
! colspan="2" |Disease | |||
!History | |||
!Mucosal bleeding | |||
!Petechia | |||
!Ecchymoses | |||
!Menorrhagia | |||
!Hematoma | |||
!Hemarthrosis | |||
!Plt | |||
!BT | |||
!PT | |||
!PTT | |||
!TT | |||
!Comments | |||
|- | |- | ||
! align="center" style="padding: 5px 5px; background: #DCDCDC;" |Thromobcytosis | ! align="center" style="padding: 5px 5px; background: #DCDCDC;" |Thromobcytosis | ||
Line 306: | Line 322: | ||
| align="center" style="background:#F5F5F5;" | Nl | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="center" style="background:#F5F5F5;" | See the table below for the details about different types. | | align="center" style="background:#F5F5F5;" | See the table below for the details about different types. | ||
|- | |||
!Subcategory | |||
! colspan="2" |Disease | |||
!History | |||
!Mucosal bleeding | |||
!Petechia | |||
!Ecchymoses | |||
!Menorrhagia | |||
!Hematoma | |||
!Hemarthrosis | |||
!Plt | |||
!BT | |||
!PT | |||
!PTT | |||
!TT | |||
!Comments | |||
|- | |- | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Vessel wall disorders | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Vessel wall disorders | ||
Line 355: | Line 387: | ||
|− | |− | ||
|- | |- | ||
! rowspan=" | ! rowspan="15" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Coagulation factor disorders | ||
<ref name="pmid28966616" /> | <ref name="pmid28966616" /> | ||
! align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Fibrinogen]] deficiency | ! align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Fibrinogen]] deficiency | ||
Line 395: | Line 427: | ||
* The severity of bleeding in patients with fibrinogen disorders can be mild or severe, with higher bleeding risk in those with afibrinogenemia or lower levels of functional fibrinogen. The age of onset is also variable, with earlier onset in those with more severe deficiency. | * The severity of bleeding in patients with fibrinogen disorders can be mild or severe, with higher bleeding risk in those with afibrinogenemia or lower levels of functional fibrinogen. The age of onset is also variable, with earlier onset in those with more severe deficiency. | ||
|- | |||
!Subcategory | |||
! colspan="2" |Disease | |||
!History | |||
!Mucosal bleeding | |||
!Petechia | |||
!Ecchymoses | |||
!Menorrhagia | |||
!Hematoma | |||
!Hemarthrosis | |||
!Plt | |||
!BT | |||
!PT | |||
!PTT | |||
!TT | |||
!Comments | |||
|- | |- | ||
! colspan="3" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Prothrombin deficiency]] | ! colspan="3" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Prothrombin deficiency]] | ||
Line 504: | Line 552: | ||
|Nl | |Nl | ||
| | | | ||
|- | |||
!Subcategory | |||
! colspan="2" |Disease | |||
!History | |||
!Mucosal bleeding | |||
!Petechia | |||
!Ecchymoses | |||
!Menorrhagia | |||
!Hematoma | |||
!Hemarthrosis | |||
!Plt | |||
!BT | |||
!PT | |||
!PTT | |||
!TT | |||
!Comments | |||
|- | |- | ||
! colspan="3" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[High-molecular-weight kininogen|High molecular weight kininogen (HMWK)]] deficiency | ! colspan="3" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[High-molecular-weight kininogen|High molecular weight kininogen (HMWK)]] deficiency | ||
Line 616: | Line 680: | ||
|Nl | |Nl | ||
| − | | − | ||
|- | |||
!Subcategory | |||
! colspan="2" |Disease | |||
!History | |||
!Mucosal bleeding | |||
!Petechia | |||
!Ecchymoses | |||
!Menorrhagia | |||
!Hematoma | |||
!Hemarthrosis | |||
!Plt | |||
!BT | |||
!PT | |||
!PTT | |||
!TT | |||
!Comments | |||
|- | |- | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Rare diseases | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Rare diseases |
Revision as of 16:04, 19 October 2018
Differential Diagnosis
Different causes of the bleeding disorders can be differentiated based on their clinical manifestation and laboratory findings.
These features have discussed in the below table:
Category | Subcategory | Disease | History | Clinical manifestation | Laboratory testing | Comments | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mucosal bleeding | Petechia | Ecchymoses | Menorrhagia | Hematoma | Hemarthrosis | Plt | BT | PT | PTT | TT | ||||||
Platelet disorders | Thrombocytopenia | Infection-Induced thrombocytopenia |
|
+ | + | + | + | + | + | ↓ | ↑ | Nl | Nl | Nl | − | |
Medications-Induced thrombocytopenia |
|
+ | + | + | + | + | + | ↓ | ↑ | Nl | Nl | Nl | Most important part of treatment is discontinuing of the medication. | |||
Heparin-Induced thrombocytopenia |
|
+ | + | + | + | + | + | ↓ | ↑ | Nl | Nl | ↑ | For more information click here: Heparin-induced thrombocytopenia. | |||
Immune Thrombocytopenic Purpura (ITP) |
|
+ | + | + | + | + | + | ↓ | ↑ | Nl | Nl | Nl | − | |||
Inherited Thrombocytopenia |
|
+ | + | + | + | + | + | ↓ | ↑ | Nl | Nl | Nl | − | |||
Thrombotic Thrombocytopenic Purpura (TTP) | History of:
|
+ | + | + | + | + | + | ↓ | ↑ | Nl | Nl | Nl | − | |||
Hemolytic Uremic Syndrome | History of: | + | + | + | + | + | + | ↓ | ↑ | Nl | Nl | Nl | − | |||
Subcategory | Disease | History | Mucosal bleeding | Petechia | Ecchymoses | Menorrhagia | Hematoma | Hemarthrosis | Plt | BT | PT | PTT | TT | Comments | ||
Thromobcytosis | Iron deficiency anemia
Inflammatory diseases |
− | − | − | − | ± | ± | ↑ | Nl or ↑ | Nl | Nl | Nl | − | |||
Qualitative Disorders of Platelet Function | Inherited Disorders of Platelet Function | Glanzmann’s thrombasthenia |
|
+ | + | + | + | − | Rare | Nl or ↓ | ↑ | Nl | Nl | Nl |
| |
Bernard-Soulier syndrome |
|
+ | + | + | + | − | − | Nl or ↓ | ↑ | Nl | Nl | Nl |
| |||
Wiskott-Aldrich syndrome |
|
+ | + | + | + | − | − | Nl or ↓ | ↑ | Nl | Nl | Nl | ||||
Platelet storage pool disorder: |
|
+ | + | + | + | − | − | Nl or ↓ | ↑ | Nl | Nl | Nl |
| |||
Acquired Disorders of Platelet Function |
|
+ | + | + | + | ± | ± | Nl or ↓ | ↑ | Nl | Nl | Nl | − | |||
Von Willebrand Disease |
|
+ | + | + | + | ± | ± | ↑ | Nl | ↑ | ↑ | Nl | See the table below for the details about different types. | |||
Subcategory | Disease | History | Mucosal bleeding | Petechia | Ecchymoses | Menorrhagia | Hematoma | Hemarthrosis | Plt | BT | PT | PTT | TT | Comments | ||
Vessel wall disorders | Metabolic and Inflammatory Disorders |
|
|
− | + | + | ± | − | − | Nl | Nl or ↑ | Nl | Nl | Nl | − | |
Inherited Disorders of the Vessel Wall |
|
− | + | + | ± | − | − | Nl | Nl or ↑ | Nl | Nl | Nl | − | |||
Coagulation factor disorders | Fibrinogen deficiency | Different types of the fibrinogen disorders: |
|
− | − | + | + | ± | + | Nl | ↑ | ↑ | ↑ | ↑ |
| |
Subcategory | Disease | History | Mucosal bleeding | Petechia | Ecchymoses | Menorrhagia | Hematoma | Hemarthrosis | Plt | BT | PT | PTT | TT | Comments | ||
Prothrombin deficiency |
|
− | + | + | + | + | + | Nl | Nl | ↑ | ↑ | ↑ | − | |||
Factor V deficiency |
|
− | _ | + | + | + | + | Nl | ↑ | ↑ | ↑ | Nl | The severity of bleeding is only partly related to the degree of factor V deficiency. Some patients with undetectable plasma levels of factor V experience only relatively mild bleeding. | |||
Factor VII deficiency |
|
+ | + | + | Nl | ↑ | Nl | Nl | Thrombosis occurs in inherited factor VII deficiency most cases are associated with the administration of factor VII replacement therapy | |||||||
Factor X deficiency |
|
+ | + | + | + | + | Nl | Nl | ↑ | ↑ | Nl | − | ||||
Factor XII deficiency |
|
_ | _ | _ | _ | _ | Nl | Nl | Nl | ↑ | Nl | |||||
Subcategory | Disease | History | Mucosal bleeding | Petechia | Ecchymoses | Menorrhagia | Hematoma | Hemarthrosis | Plt | BT | PT | PTT | TT | Comments | ||
High molecular weight kininogen (HMWK) deficiency |
|
_ | _ | _ | _ | _ | Nl | Nl | Nl | ↑ | Nl | |||||
Prekallikrein deficiency |
|
_ | _ | _ | _ | _ | Nl | Nl | Nl | ↑ | Nl | |||||
Factor XIII deficiency |
|
|
± | ± | ± | ± | ± | ± | Nl | Nl | Nl or ↑ | Nl | Nl |
| ||
Hemophilia | Type A deficiency |
|
− | − | − | + | + | + | Nl | Nl | Nl | ↑ | Nl | − | ||
Type B deficiency |
|
− | − | − | + | + | + | Nl | Nl | Nl | ↑ | Nl | − | |||
Type C deficiency |
|
− | − | − | + | Rare | Rare | Nl | Nl | Nl | ↑ | Nl | − | |||
Subcategory | Disease | History | Mucosal bleeding | Petechia | Ecchymoses | Menorrhagia | Hematoma | Hemarthrosis | Plt | BT | PT | PTT | TT | Comments | ||
Rare diseases | Disseminated Intravascular Coagulation |
|
+ | + | + | + | + | + | ↓ | ↑ | ↑ | ↑ | Nl | − | ||
Vitamin K Deficiency |
|
+ | − | + | + | + | + | Nl | ↑ | ↑ | Nl or mildly prolonged | Nl | − |
Different types of Von-Willebrand diseases can be differentiated from each other based on the following table:
Type of VWD | Type of factor deficiency | Prevalence | Inheritance pattern | Clinical manifestations | VWF activity | RIPA | Factor VIII | |
---|---|---|---|---|---|---|---|---|
Type 1 | Quantitative/ partial | 60-70% | AD |
|
↓ | ↓ | ↓ | |
Type 2 | 2A | Qualitative | 10% | AD/AR |
|
↓ | ↓ | N or ↓ |
2B | Qualitative | 5% | AD |
|
↓ | ↑ | N or ↓ | |
2M | Qualitative | <1% | AD/AR |
|
↓ | ↓ | N or ↓ | |
2N | Qualitative | <1% | AR |
|
N | N | ↓ | |
Type 3 | Complete deficiency | 1-2% | AR |
|
Absent | ↓ | Low, 1-10% |
For more information on Von Willebrand disease, click here.
- ↑ Invalid
<ref>
tag; no text was provided for refs namedpmid28966616